Heart Test Laboratories Inc. Warrant (HSCSW) financials · rev $4.3K
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Heart Test Laboratories Inc. Warrant (HSCSW) rev $4.3K.
| Line | FY2026 | FY2025 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Revenue | $4.32K | $4.35K | |
| Cost of Revenue | $1.77K | $1.88K | |
| Gross Profit | $2.55K | $2.47K | |
| Operating Income | −$8.41M | −$8.35M | |
| Net Income | −$9.14M | −$8.77M | |
| EPS (Diluted) | −$3.48 | −$9.34 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2026 | FY2025 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $5.26M | $4.22M | |
| Current Assets | $2.58M | $2.17M | |
| Cash & Equivalents | $1.66M | $1.10M | |
| Inventory | $655.63K | $650.27K | |
| PP&E | $39.31K | $63.55K | |
| Total Liabilities | $5.04M | $4.02M | |
| Current Liabilities | $4.86M | $3.70M | |
| Shareholders' Equity | $226.06K | $205.17K | |
| Retained Earnings | −$85.27M | −$76.13M |
| Line | FY2026 | FY2025 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$7.43M | −$7.41M | |
| CapEx | $3.55K | $3.16K | |
| Investing Cash Flow | −$44.45K | −$30.19K | |
| Financing Cash Flow | $8.03M | $2.73M | |
| Net Change in Cash | $558.72K | −$4.71M | |
| Free Cash Flow | −$7.43M | −$7.42M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2026
FAQ
What is HSCSW P/E and revenue?
Heart Test Laboratories Inc. Warrant (HSCSW) rev $4.3K.
What is HSCSW revenue?
Heart Test Laboratories Inc. Warrant last cached revenue is $4.32K (FY2026).
Is HSCSW profitable?
Heart Test Laboratories Inc. Warrant last cached net income is -$9.14M (FY2026).
What are HSCSW total assets?
Heart Test Laboratories Inc. Warrant last cached total assets are $5.26M (FY2026).
What is HSCSW free cash flow?
Heart Test Laboratories Inc. Warrant last cached free cash flow is -$7.43M (FY2026).
Not investment advice. Figures as reported in company filings, not a live feed.